Product Description
Adenosine monophosphate, also known as 5'-adenylic acid and abbreviated AMP, is a nucleotide that is found in RNA. AMP is used as a dietary supplement to boost immune activity, and is also used as a substitute sweetener to aid in the maintenance of a low-calorie diet. (Sourced from: https://pubchem.ncbi.nlm.nih.gov/compound/Adenosine-monophosphate#section=Pharmacology-and-Biochemistry)
Mechanisms of Action: No Mechanism
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Inhalant,Intravenous,Oral
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: Pakistan | Russia | Taiwan | United Arab Emirates
Approved Indications: None
Known Adverse Events: None
Company: Amgen
Company Location: THOUSAND OAKS CA 91320
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Phase 4: Asthma
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
|---|---|---|---|---|---|
| ChiCTR2400089222 | N/A |
Not yet recruiting |
Cesarean Section|Anemia|Intestinal Diseases |
2025-08-31 |
|
| H-1-2011-023 | N/A |
Completed |
Migraine Disorders|Migraine without Aura|Migraine with Aura |
2012-06-01 |
|
| ACTRN12606000488505 | P4 |
Completed |
Asthma |
2008-11-28 |
|
| CTR20233188 | N/A |
Unknown Status |
Insulin Resistance |
None |